Articles

Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemia

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Center for Cell Engineering, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
Weill Cornell Medical College, Hematology and Medical Oncology, Joan and Sanford I. Weill Department of Medicine, New York
Kite-A Gilead Company, Foster City
Sloan Kettering Institute, New York
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Center for Cell Engineering, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
Haematologica Early view Oct 13, 2020 https://doi.org/10.3324/haematol.2020.251686